| Schedule of Earning Per Shares, Basic and Diluted |
The
schedule of loss per share, basic and diluted is as follows:
Schedule
of Earning Per Shares, Basic and Diluted
| For
The Three Months Ended June 30, | |
2026 | | |
2025 | |
| Net loss | |
$ | (1,513,235 | ) | |
$ | (930,715 | ) |
| Deemed dividends | |
| (981,146 | ) | |
| - | |
| Net loss attributable
to common stockholders | |
| (2,494,381 | ) | |
| (930,715 | ) |
| Weighted average shares outstanding –
basic and diluted | |
| 6,928,023 | | |
| 2,826,468 | |
| Basic and diluted net loss per share | |
$ | (0.36 | ) | |
$ | (0.33 | ) |
| For
The Six Months Ended June 30, | |
2026 | | |
2025 | |
| Net loss | |
$ | (3,292,452 | ) | |
$ | (1,757,914) | |
| Deemed dividends | |
| (1,068,758 | ) | |
| - | |
| Net loss attributable
to common stockholders | |
| (4,361,210 | ) | |
| (1,757,914 | ) |
| Weighted average shares outstanding –
basic and diluted | |
| 5,647,674 | | |
| 2,806,841 | |
| Basic and diluted net loss per share | |
$ | (0.77 | ) | |
$ | (0.63 | ) |
|
| Schedule of Share-based Equity Awards and Warrants Excluded from Computation of Earnings |
Schedule
of Share-based Equity Awards and Warrants Excluded from Computation of Earnings
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three
Months Ended June
30, | | |
Six
Months Ended June
30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Shares to be issued to Abaca shareholders | |
| - | | |
| 37,500 | | |
| - | | |
| 37,500 | |
| Stock options | |
| 538,618 | | |
| 160,841 | | |
| 538,618 | | |
| 160,841 | |
| Restricted stock | |
| - | | |
| 1,448 | | |
| - | | |
| 1,448 | |
| Conversion of preferred stock | |
| 4,440 | | |
| 4,440 | | |
| 4,440 | | |
| 4,440 | |
| Series B Convertible Preferred Stock(1) | |
| 41,744,615 | | |
| - | | |
| 41,744,615 | | |
| - | |
| Warrants (1) | |
| 10,445,506 | | |
| 639,329 | | |
| 10,445,506 | | |
| 639,329 | |
| Total | |
| 52,733,179 | | |
| 843,558 | | |
| 52,733,179 | | |
| 843,558 | |
| (1) | The
number of shares attributable to the Series B Convertible Preferred Stock reflects the temporarily reduced $0.65 conversion and exercise price in effect during the
Offer Period. This price reverted to $1.5528 on August 1, 2026, which reduced the number
of as-converted shares reflected in future periods for the Series B Convertible Preferred
Stock to 17,474,249. |
|